Source: Gynecologic Oncology. Unidade: FMRP
Subjects: GONADOTROFINA CORIÔNICA, QUIMIOTERAPIA, TROFOBLASTO, GRAVIDEZ
ABNT
ABRÃO, Renato Antonio et al. Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactnomycin and combination regimens. Gynecologic Oncology, v. 108, n. 1, p. 149-153, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ygyno.2007.09.006. Acesso em: 01 nov. 2024.APA
Abrão, R. A., Andrade, J. M. de, Tiezzi, D. G., Marana, H. R. C., Reis, F. J. C. dos, & Clagnan, W. S. (2008). Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactnomycin and combination regimens. Gynecologic Oncology, 108( 1), 149-153. doi:10.1016/j.ygyno.2007.09.006NLM
Abrão RA, Andrade JM de, Tiezzi DG, Marana HRC, Reis FJC dos, Clagnan WS. Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactnomycin and combination regimens [Internet]. Gynecologic Oncology. 2008 ; 108( 1): 149-153.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.ygyno.2007.09.006Vancouver
Abrão RA, Andrade JM de, Tiezzi DG, Marana HRC, Reis FJC dos, Clagnan WS. Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactnomycin and combination regimens [Internet]. Gynecologic Oncology. 2008 ; 108( 1): 149-153.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.ygyno.2007.09.006